drugset / Trial / NCT01221844

Bovine Lactoferrin to Prevent and Cure Iron Deficiency and Iron Deficiency Anemia in Complicated Pregnancies

NCT01221844 ↗

Phase 4 Completed 300 enrolled Clinica Fabia Mater
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether bovine lactoferrin is effective in preventing and curing iron deficiency and iron deficiency anemia in Hereditary Thrombophilia affected women during pregnancy. The proposed clinical trial is considered as PHASE IV because in Italy bLf is commercialized by Grunenthal, as Lattoglobina® (capsules with 100 mg of bLf), to prevent and cure iron deficiency and iron deficiency anemia in pregnant women.

Timeline

Start
2010-02
Primary completion
2011-03
Completion
2011-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator ferrous sulfate Small molecule 540 mg Oral